# INRange Systems

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/inrange-systems

- Industry: Medical Devices & Equipment
- Headquarters: Altoona, US
- Website: www.inrangesystems.com
- Total disclosed funding: $11M
- Latest round: Series B (Dec 31, 2014)
- Investors on record: 2

## About

INRange Systems, Inc. is dedicated to providing innovative solutions in the healthcare technology sector, focusing on enhancing medication management for caregivers and patients.INRange Systems, Inc. specializes in developing healthcare technology solutions tailored for medication management. The company is headquartered in Altoona, US. The CEO, FASCP PD Vince Da Grava, has a history in healthcare innovation. INRange has successfully completed 14 deals, with the most recent investment occurring on November 4, 2015, when the company raised USD 0.17 mn in VC financing from unspecified investors, marking the total amount raised at USD 0.17 mn.INRange Systems develops MyEMMA, a medication management platform aimed at improving the administration process for caregivers and residents in healthcare settings. This product enhances safety and reliability compared to traditional self-administration methods. MyEMMA simplifies medication management, making it user-friendly for caregivers and residents in senior living facilities, behavioral health organizations, and pharmacies, primarily marketed across the United States.INRange Systems operates on a revenue model that includes direct-to-consumer sales and partnerships with healthcare facilities and pharmacies for the MyEMMA system. Revenue is generated through subscription-based service agreements or licensing fees for software access, along with comprehensive support and training for effective implementation of their medication management solutions.The company aims to expand its product line with upcoming features for MyEMMA, though specific release dates are not disclosed. Additionally, INRange Systems is targeting expansion into new geographic regions within the United States to enhance its market presence. The funding raised in November 2015, amounting to USD 0.17 mn, will support these initiatives, enabling further development of their medication management solutions and facilitating expansion efforts.

## Funding rounds

- Series B, Dec 31, 2014, $7.1M — Hopewell Ventures
- Series B, Jun 1, 2010 — Hopewell Ventures, Ceres Venture Fund
- Series B, Jan 14, 2009, $4M — Hopewell Ventures

## Investors

- Hopewell Ventures (https://capitalatlas.ai/funds/hopewell-ventures) — Series B
- Ceres Venture Fund (https://capitalatlas.ai/funds/ceres-venture-fund) — Series B